MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Smith & Nephew PLC ADR

Закрыт

33.49 1.24

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

33.27

Макс.

33.76

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

22.818

66.418

Дивидендная доходность

2.43

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+4.42% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.43%

2.36%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.3B

14B

Предыдущая цена открытия

32.25

Предыдущая цена закрытия

33.49

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 апр. 2026 г., 17:04 UTC

Главные движущие силы рынка

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 апр. 2026 г., 00:00 UTC

Отчет
Приобретения, слияния, поглощения

Big Yachts, Big Bucks -- Barrons.com

10 апр. 2026 г., 21:55 UTC

Приобретения, слияния, поглощения

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 апр. 2026 г., 21:01 UTC

Отчет

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Energy & Utilities Roundup: Market Talk

10 апр. 2026 г., 20:50 UTC

Обсуждения рынка
Главные новостные события

Basic Materials Roundup: Market Talk

10 апр. 2026 г., 20:50 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

10 апр. 2026 г., 20:31 UTC

Обсуждения рынка

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 апр. 2026 г., 20:10 UTC

Приобретения, слияния, поглощения

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 апр. 2026 г., 19:15 UTC

Обсуждения рынка

Global Energy Roundup: Market Talk

10 апр. 2026 г., 19:15 UTC

Обсуждения рынка

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 апр. 2026 г., 19:08 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

10 апр. 2026 г., 19:08 UTC

Обсуждения рынка

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 апр. 2026 г., 18:38 UTC

Обсуждения рынка

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 апр. 2026 г., 18:25 UTC

Обсуждения рынка
Главные новостные события

Precious Metals Finish With Weekly Gains -- Market Talk

10 апр. 2026 г., 18:05 UTC

Обсуждения рынка

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 апр. 2026 г., 17:31 UTC

Обсуждения рынка
Главные новостные события

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 апр. 2026 г., 17:26 UTC

Отчет

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 апр. 2026 г., 17:10 UTC

Обсуждения рынка

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 апр. 2026 г., 17:00 UTC

Главные новостные события

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 апр. 2026 г., 16:20 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

10 апр. 2026 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

10 апр. 2026 г., 16:12 UTC

Отчет

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 апр. 2026 г., 16:11 UTC

Отчет

Partners Group: Traditional Programs Contributed $3.3B

10 апр. 2026 г., 16:10 UTC

Отчет

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 апр. 2026 г., 16:10 UTC

Отчет

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 апр. 2026 г., 16:10 UTC

Отчет

Partners Group 1Q New Client Demand $8.3B

10 апр. 2026 г., 16:09 UTC

Отчет

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 апр. 2026 г., 15:54 UTC

Приобретения, слияния, поглощения

Plenitude Completes Acquisition of Acea Energia

10 апр. 2026 г., 15:38 UTC

Обсуждения рынка

Global Energy Roundup: Market Talk

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

4.42% рост

Прогноз на 12 месяцев

Средняя 34.96 USD  4.42%

Максимум 35 USD

Минимум 34.91 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat